CEO: | Daniel Lee |
CFO: | David Cocke |
Independent Non-Executive Director: | Trevor Phillips |
Independent Non-Executive Director: | Brian Phillips |
Non-Executive Chairman: | Jonathan Glenn |
Non-Executive Dir: | Shervanthi Homer - Vanniasinkam |
Address: | Unit 3, Phoenix Court, Lotherton Way, Garforth, United Kingdom, LS25 2GY |
Phone: | +44 (0) 1904 567 609 |
Fax: | +44 (0) 1904 380 517 |
Website: | http://www.tissueregenix.com/ |
Sector: | Financials(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BNTXR104 |
Currency | UK Pounds |
Share Price | 59.50p |
Change Today | 2.00p |
% Change | 3.48 % |
52 Week High | 74.00 |
52 Week Low | 50.40 |
Volume | 72,269 |
Shares Issued | 71.40m |
Market Cap | £42.48m |
RiskGrade | 22 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:07 | 6,272 @ 59.50p |
15:02 | 4,986 @ 60.00p |
13:31 | 3,400 @ 59.50p |
13:30 | 464 @ 58.43p |
11:47 | 16,136 @ 59.50p |
You are here: research